Evidence map›Paper›PMID 36359826›Full record

ArticleCells2022

Identification of SLC3A2 as a Potential Therapeutic Target of Osteoarthritis Involved in Ferroptosis by Integrating Bioinformatics, Clinical Factors and Experiments.

Hailong Liu, Zengfa Deng, Baoxi Yu, Hui Liu, Zhijian Yang, Anyu Zeng, Ming Fu

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Battling pain from osteoarthritis: causing novel cell death.Acta biochimica et biophysica Sinica · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hailong LiuDepartment of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Zengfa DengDepartment of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.ORCID 0000-0001-8724-9500
Baoxi YuDepartment of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.ORCID 0000-0002-5662-1258
Hui LiuDepartment of Ultrasound in Medicine, The People's Hospital of PingYi County, Linyi 273399, China.
Zhijian YangDepartment of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.ORCID 0000-0001-7193-7229
Anyu ZengDepartment of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Ming FuDepartment of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.ORCID 0000-0002-3245-0845
Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a type of arthritis that causes joint pain and limited mobility. In recent years, some studies have shown that the pathological process of OA chondrocytes is related to ferroptosis. Our study aims to identify and validate differentially expressed ferroptosis-related genes (DEFRGs) in OA chondrocytes and to investigate the potential molecular mechanisms. RNA-sequencing and microarray datasets were downloaded from Gene Expression Omnibus (GEO) data repository. Differentially expressed genes (DEGs) were screened by four methods: limma-voom, edgeR, DESeq2, and Wilcoxon rank-sum test. Weighted correlation network analysis (WGCNA), protein-protein interactions (PPI), and cytoHubba of Cytoscape were applied to identify hub genes. Clinical OA cartilage specimens were collected for quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis, western blotting (WB), histological staining, transmission electron microscopy (TEM), and transfection. Sankey diagram was used to visualize the relationships between the expression level of SLC3A2 in the damaged area and clinical factors. Based on bioinformatics analysis, clinical factors, and experiment validation, SLC3A2 was identified as a hub gene. It was down-regulated in OA cartilage compared to normal cartilage (

Indexed as

FerroptosisFusion Regulatory Protein 1, Heavy ChainOsteoarthritisCartilageChondrocytesComputational BiologyHumansFusion Regulatory Protein 1, Heavy ChainSLC3A2 protein, humancartilageferroptosisGEOosteoarthritis

Identifiers

PMID36359826
PMCPMC9657506
OpenAlexW4307942646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.